Valuation: Sartorius AG

Market Cap 14.5B 16.5B 13.36B 12.49B 23.42B 1,557B 23.85B 160B 62.07B 768B 61.97B 60.61B 2,668B P/E 2026 *
60.4x
P/E 2027 * 47.3x
Enterprise Value 18.06B 20.56B 16.64B 15.56B 29.18B 1,940B 29.72B 200B 77.34B 956B 77.22B 75.53B 3,324B EV / Sales 2026 *
4.82x
EV / Sales 2027 * 4.32x
Free-Float
35.87%
Yield 2026 *
0.36%
Yield 2027 * 0.43%
1 week+5.82%
Current month-6.57%
1 month-1.89%
3 months+8.07%
6 months-6.42%
Current year-7.55%
1 week 210.1
Extreme 210.1
231.9
1 month 209.9
Extreme 209.9
251.2
3 years 168.35
Extreme 168.35
383.4
5 years 168.35
Extreme 168.35
629.6
10 years 58.72
Extreme 58.722
629.6
Manager TitleAgeSince
Chief Executive Officer 59 2025-06-29
Director of Finance/CFO 55 2024-03-31
Chief Operating Officer 69 2000-12-31
Director TitleAgeSince
Director/Board Member 62 2002-08-31
Chairman 69 2017-07-08
Director/Board Member 57 2010-09-30
Change 5-day change 1-year change 3-year change Capi.($)
-0.15%-3.96%+7.51%-26.18% 16.5B
-3.26%-2.78%+24.22%+51.43% 1.52B
-1.04%-1.99%-31.20%+25.76% 1.1B
+10.73%-1.10%-51.90%-83.98% 922M
-3.65%-5.09%-22.99%-52.21% 640M
-1.46%+6.40%-38.63%-54.81% 587M
-0.77%-2.28%+26.57%-54.71% 434M
-1.49%-0.32%-54.34%-60.56% 385M
+0.11%+1.47%+32.45%+24.20% 340M
-1.44%+1.18%-23.33%-23.15% 341M
Average -0.20%-0.12%-13.16%-25.42% 696.18M
Weighted average by Cap. -0.09%-0.79%+1.54%-22.63%

Financials

2026 *2027 *
Net sales 3.75B 4.27B 3.46B 3.23B 6.06B 403B 6.17B 41.46B 16.06B 199B 16.04B 15.68B 690B 4.11B 4.67B 3.78B 3.54B 6.63B 441B 6.75B 45.38B 17.58B 217B 17.55B 17.17B 755B
Net income 257M 293M 237M 222M 416M 27.63B 423M 2.84B 1.1B 13.62B 1.1B 1.08B 47.34B 328M 374M 302M 283M 530M 35.25B 540M 3.63B 1.4B 17.37B 1.4B 1.37B 60.38B
Net Debt 3.57B 4.06B 3.29B 3.07B 5.76B 383B 5.87B 39.42B 15.27B 189B 15.25B 14.91B 656B 3.26B 3.71B 3B 2.81B 5.26B 350B 5.36B 36.02B 13.95B 173B 13.93B 13.62B 600B
Logo Sartorius AG
Sartorius AG is a Germany-based supplier of pharmaceutical and laboratory equipment. It operates in two segments: bioprocess solutions and lab products and services. The bioprocess solutions segment offers integrated solutions for biopharmaceutical manufacture, such as filters for sterilization of biopharmaceutical media, single-use bags for cell cultivation and storage of biopharmaceuticals, membrane adsorbers for purification in bioprocesses, filter technology for clarification, among others. The lab Products and Services segment provides instruments, consumables, and services for laboratories, including laboratory balances, laboratory water systems for storage of purified water, electronic pipettes, filter systems for sample preparation, and membrane filter systems for sterility testing of parenteral.
Employees
-
Date Price Change
26-06-26 228.70 -0.13%
26-06-25 €229.00 +4.81%
26-06-24 €218.50 +2.82%
26-06-23 €212.50 +0.62%
26-06-22 €211.20 -0.89%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
230.20EUR
Average target price
266.32EUR
Spread / Average Target
+15.69%

Quarterly revenue - Rate of surprise